Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Mortality Factor 4 (MORF4) (Middle Region) Peptide

MORF4 Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN980185
  • Target See all MORF4 products
    MORF4 (Mortality Factor 4 (MORF4))
    Protein Region
    Middle Region
    Origin
    Human
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), Western Blotting (WB)
    Characteristics
    This is a synthetic peptide designed for use in combination with anti-MORF4 antibody (Catalog #: ARP47609_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
    Purification
    Purified
  • Application Notes
    Each Investigator should determine their own optimal working dilution for specific applications.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
    Concentration
    1 mg/mL
    Buffer
    Final peptide concentration is 1 mg/mL in PBS.
    Handling Advice
    Avoid repeated freeze-thaw cycles.
    Storage
    -20 °C
    Storage Comment
    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target
    MORF4 (Mortality Factor 4 (MORF4))
    Synonyms
    CSR Peptide, CSRB Peptide, SEN Peptide, SEN1 Peptide, mortality factor 4 (pseudogene) Peptide, MORF4 Peptide
    Background
    Cellular senescence, the terminal nondividing state that normal cells enter following completion of their proliferative potential, is the dominant phenotype in hybrids of normal and immortal cells. Fusions of immortal human cell lines with each other have led to their assignment to 1 of several complementation groups. MORF4 is a gene on chromosome 4 that induces a senescent-like phenotype in cell lines assigned to complementation group B.Cellular senescence, the terminal nondividing state that normal cells enter following completion of their proliferative potential, is the dominant phenotype in hybrids of normal and immortal cells. Fusions of immortal human cell lines with each other have led to their assignment to 1 of several complementation groups. MORF4 is a gene on chromosome 4 that induces a senescent-like phenotype in cell lines assigned to complementation group B.[supplied by OMIM].

    Alias Symbols: CSR, CSRB, SEN, SEN1

    Protein Interaction Partner: SIN3A

    Protein Size: 235
    Molecular Weight
    27 kDa
    Gene ID
    10934
    NCBI Accession
    NM_006792, NP_006783
You are here:
Support